Found 23 matching trials
A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects
PHASE1Compare the effect of exenatide (therapeutic and supratherapeutic concentra...
A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes
PHASE3Phase 3 study to compare treatment with ITCA 650 to sitagliptin when added ...
Location
Intarcia Therapeutics, Inc
Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide
N/AThe purpose of this substudy is to obtain CGM data from individuals taking ...
Location
International Diabetes Center
Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects
PHASE4The aim of the study is to use Exenatide long-acting release (LAR) \[Bydure...
Location
Dept of clinical science and education Karolinska Institutet Södersjukhuset
A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
PHASE1A Phase 1b, Exploratory, Randomized, Partially Single Blinded, Placebo and ...
A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes
PHASE3Phase 3 study to examine treatment with ITCA 650 compared to glimepiride wh...
Location
Intarcia Therapeutics, Inc
A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)
PHASE1This study will compare graded glucose infusion (GGI) to the hyperglycemic ...
Location
Multiple Locations
Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)
PHASE3A Randomized, Open-Label, Multicenter, Comparator-Controlled Study to Exami...
Location
Research Site 182
Intravenous Exenatide (Byetta) During Surgery
PHASE1The purpose of this project is to study if intravenous Exenatide is effecti...
Location
University of Pennsylvania
A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)
PHASE3This study will compare the effects of commercially manufactured exenatide ...